TrialThe Journal of clinical endocrinology and metabolism2021

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome.

Graeme L Fraser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.